MedPath

GE HEALTHCARE PTE. LTD.

🇸🇬Singapore
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

HSA:12

Drug Approvals

SONAZOID POWDER AND SOLVENT FOR DISPERSION FOR INJECTION 16 MICROLITRE PER VIAL

Approval Date
Jan 6, 2021
HSA

CLARISCAN SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE 0.5 MMOL/ML

Approval Date
May 24, 2019
HSA

CLARISCAN SOLUTION FOR INJECTION IN VIAL 0.5 MMOL/ML

Approval Date
May 24, 2019
HSA

VIZAMYL SOLUTION FOR INJECTION 150 MBq/mL

Approval Date
Mar 6, 2018
HSA

DATSCAN SOLUTION FOR INJECTION 74 MBQ/ML

Approval Date
Sep 4, 2017
HSA

META-IODOBENZYLGUANIDINE (I-131) INJECTION FOR THERAPEUTIC USE

Approval Date
May 28, 2002
HSA

THERACAP 131TM CAPSULE

Approval Date
May 11, 2002
HSA

MYOVIEW FOR INJECTION 0.23 mg/vial

Approval Date
Feb 25, 2002
HSA

VISIPAQUE INJECTION 320 mgI/ml

Approval Date
Aug 28, 1996
HSA

VISIPAQUE INJECTION 270 mgI/ml

Approval Date
Aug 28, 1996
HSA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.